Menu
1 min read · estimated
APPROVED USE
What FDA approved
Adults and pediatric patients age two or older with unresectable or metastatic alveolar soft part sarcoma.
LAMPGEN ANALYSIS
Why it matters
The approval extends PD-L1 blockade to a rare sarcoma across adult and pediatric age groups.
What research teams should watch
Verify specialist histology review, disease extent, and pediatric dosing criteria at referral.
PRIMARY RECORDS